
Bernhard Wernly
@bernhardwernly
MD, MScPH, PhD; Evidence-based medicine and public health. Si vis pacem para bellum.
ID: 1049315527590662144
08-10-2018 15:08:11
1,1K Tweet
173 Followers
263 Following



@GeorgSemmler just defended his Ph.D. thesis on non-invasive risk stratification: 1 Gastro, 2 J Hepatol's, 1 Hepatology, 1 CGH, 1 Eur Radiol - best of Vienna Hepatic Hemodynamic Lab! Few weeks after Mathias Jachs with a similarly impressive performance. 🙌🥳🍾 #LiverTwitter


Dear Friends -- We've had many great posts Sensible Medicine but today's post on guidelines is one of the best. Please do read it. I LOVED it. And agree 100% sensible-med.com/p/from-guideli… cc Vinay Prasad MD MPH Adam Cifu



Very honored that our #Editorial is now published in The Lancet discussing this recent large trial ➡️ lmy.de/cqLt 🏥 „Transcatheter aortic valve replacement for pure aortic regurgitation“ #TAVR #CardioTwitter Bernhard Wernly TAVR Bot Uniklinik Düsseldorf Heinrich-Heine-Universität Düsseldorf AGIK

#Data is key 🔑 for #Science. Here 🔗 rdcu.be/dDYDD , we publish the characteristics of a large 🇪🇺 #ICU dataset, made publicly available on #Physionet 📲🌍 Data Science Central IntensiveCareNetwork Bernhard Wernly Elie Azoulay Jan De Waele MD Maurizio Cecconi Otavio Ranzani Katia Donadello



There should be a ban on subjective endpoints in unblinded trial. 3rd of 3 Hotline trials in this European Society of Cardiology session with no blinding. Do a placebo control procedure or use an all-cause mortality to avoid bias.



#LiverTwitter EASLnews Vienna Liver News Today we celabrate @GeorgSemmler a physician scientist of the #GI #Liver Division of the MedUni Wien for obtaining a #TenureTrackPosition (#IKV)



Our just published #Bayesian analysis 📊 of the CULPRIT-Shock 😱 trial generates further evidence favoring the culprit-lesion-only PCI strategy in AMI ♥️patients with cardiogenic #SHOCK and multivessel disease. Link: doi.org/10.1093/ehjacc… 📒Holger Thiele Bernhard Wernly




Steatotic liver disease affects ~30% of the global population. A Review by Mads Israelsen, Sven Francque, Emmanual Tsochatzis, & Aleksander Krag covers the recent reclassification of steatotic liver disease & how it reflects clinical practice & prognosis: hubs.li/Q02WB7xd0



